BSE filing, NSE: ABINFRA. Summary written from the filing by ALFA Finder's alert engine.
AB Infrabuild Ltd: key numbers
- Share price
- ₹12.28
- Market cap
- ₹784.4 Cr
- Revenue (annual)
- ₹256.2 Cr
- Net profit (annual)
- ₹19.34 Cr
- P/E (TTM)
- 40.1×Sector 31.7×
- Promoter holding
- 30.95%+0.00% QoQ
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AB Infrabuild Ltd
All →AB Infrabuild Board Meeting Date
A B Infrabuild will hold a board meeting on November 3, 2026 to consider quarterly and half-year results. This is an advance intimation under Regulation 29.
AB Infrabuild Bags ₹48.1 Cr Order from Government of Chhattisgarh
A B Infrabuild Limited secured a ₹48.10 Crore EPC contract from the Government of Chhattisgarh. The project involves constructing two grade separators over 18 months.
- Value
- ₹48.10 Cr
- From
- Government of Chhattisgarh
- Execution
- 18 Months
AB Infrabuild Annual General Meeting
A B Infrabuild held its 16th Annual General Meeting, transacting items including financial statement adoption, dividend declaration, and director re-appointment. The meeting concluded successfully.
AB Infrabuild Annual Report
A B Infrabuild Limited has filed its Annual Report for the financial year 2025-2026, scheduling the AGM for September 28, 2026, and seeking various approvals.
AB Infrabuild Annual General Meeting
A B Infrabuild Ltd has issued a notice for its 16th Annual General Meeting, scheduled for September 28, 2026, to consider financial statements and dividend declaration.
AB Infrabuild Dividend
A B Infrabuild Limited has announced September 21, 2026, as the record date for determining shareholder eligibility for the upcoming dividend and Annual General Meeting.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.